CD8A and melanoma: EVs derived from B16-F10 melanoma cells (B16-EV) could carry tumor antigens, facilitate maturation, activate CD8+ T cells, and increase the IFN-γ level, thus inhibiting the growth and metastasis of melanoma in mice [66].